GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » Net Issuance of Preferred Stock

U2Bio Co (XKRX:221800) Net Issuance of Preferred Stock : ₩0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is U2Bio Co Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

U2Bio Co's net issuance of preferred for the six months ended in Dec. 2023 was ₩0 Mil. The number is 0, which means that U2Bio Co has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

U2Bio Co's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2023 was ₩0 Mil.

U2Bio Co Net Issuance of Preferred Stock Historical Data

The historical data trend for U2Bio Co's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U2Bio Co Net Issuance of Preferred Stock Chart

U2Bio Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Issuance of Preferred Stock
Get a 7-Day Free Trial Premium Member Only - - - - -

U2Bio Co Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Net Issuance of Preferred Stock - - - -

U2Bio Co Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U2Bio Co Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of U2Bio Co's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

U2Bio Co (XKRX:221800) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » Net Issuance of Preferred Stock
Comparable Companies
XKRX:031860 XKRX:347740 XKRX:245620 XKRX:086040 XKRX:229000 XKRX:253840 XKRX:122310 XKRX:363250 XKRX:950200 XKRX:109820 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
N/A
Address
Basement 1, 68 Gumaro Songpagu, Seoul, KOR
Website
http://www.u2bio.co.kr
U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.

U2Bio Co (XKRX:221800) Headlines

No Headlines